Claim: 3. The composition according to claim 1 , wherein the pharmaceutically and/or cosmetically acceptable carrier comprises one or more chelating agents, emulsifiers, moisturizers, sunscreens, emollients, consistency agents, thickeners and/or viscosity agents, sensory modifiers, antioxidants, oils and/or waxes, solvents, gelling agents, preservative agents, pH correction agents, conditioning agents, surfactants, pearlizing agents, deodorants, or any combination thereof.
Other References: Aaronson, D. et al., A Road Map for Those Who Don't Know JAK-STAT, Science 296 (May 31, 2002) 1653-1655. cited by applicant
Akira, S. et al.,_Molecular Cloning of APRF, a Novel IFN-Stimulated Gene Factor 3 p91-Related Transcription Factor Involved in the gp1 30-Medlated Signaling Pathway, Cell 77 (Apr. 1994) 63-71. cited by applicant
Alvarez, A. M. R. et al.,_Lipids in Pharmaceutical and Cosmetic Preparations, Grasas y Aceites, vol. 51, Fasc. 1-2 (2000) 74-96. cited by applicant
Berg, T., Inhibition of Transcription Factors With Small Organic Molecules, Curr Opin Chem Biol. 12 (Aug. 2008) 464-471. cited by applicant
Bowman, T. et al.,_STATs in Oncogensis, Oncogene 19 (2000) 2474-2488. cited by applicant
Bradford, M.M.,_A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding, Anal Biochem 72 (1976) 248-254. cited by applicant
Deng, J. et al.,_Small Molecule Inhibitors of Stat3 Signaling Pathway, Curr Cancer Drug Targets, 7 (Feb. 2007) 91-107. cited by applicant
Ecker, A. et al., The Dark and the Bright Side of Stat3; Proto-Oncogene and Tumor-Suppressor, Front Biosci. 14 (Jan. 1, 2009) 2944-2958. cited by applicant
Elixir, Mintel, Aug. 24, 2010, 5 pages. cited by applicant
Extended European Search Report for Application No. EP 16880204.9 dated Jun. 26, 2019, 13 pages. cited by applicant
Fletcher, S. et al., Molecular Disruption of Oncogenic Signal Transducer and Activator of Transcription 3 (STAT3) Protein, Biochem Cell Biol. 87 (2009) 825-833. cited by applicant
Guidance Document on Using Cytotoxicity Tests to Estimate Starting Doses for Acute Oral Systemic Toxicity Tests, No. 129, OECD (Organisation for Economic Co-Operation and Development), OECD Environment, Health and Safety Publications Series on Testing and Assessment, Paris (2010) 54 pages. cited by applicant
Harel, S. et al.,_Pharmacologic Inhibition of JAK-STAT Signaling Promotes Hair Growth, Sci. Adv. (Oct. 23, 2015) 12 pages. cited by applicant
International Search Report and Written Opinion for Application No. PCT/BR2016/050350 dated Mar. 6, 2017, 8 pages. cited by applicant
Leyden, J. J. et al., (editors), Skin Moisturization, Cosmetic Science and Technology Series, vol. 25 (2002) 699 pages. cited by applicant
Patawa & Moringa Pre and Post Shampoo Hair Oil, Mintel, Aug. 21, 2015, 3 pages. cited by applicant
Rainforest Grown Shampoo, Mintel, Aug. 19, 2010, 4 pages. cited by applicant
Rainforest Grown Shampoo, Mintel, Oct. 21, 2011, 5 pages. cited by applicant
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/066,951, dated Oct. 2, 2019, U.S. cited by applicant
United States Patent and Trademark Office, Final Office Action received for U.S. Appl. No. 16/066,951, dated Feb. 24, 2020, U.S. cited by applicant
United States Patent and Trademark Office, Advisory Action received for U.S. Appl. No. 16/066,951, dated Jun. 18, 2020, U.S. cited by applicant
United States Patent and Trademark Office, Non-Final Office Action received for U.S. Appl. No. 16/066,951, dated Oct. 19, 2020, U.S. cited by applicant
United States Patent and Trademark Office, Notice of Allowance received for U.S. Appl. No. 16/066,951, dated Mar. 22, 2021, U.S. cited by applicant
U.S. Appl. No. 16/066,951, filed Jun. 28, 2018, U.S. Pat. No. 11,071,708, Patented. cited by applicant
No Comments.